Human myometrial and leiomyoma cells were treated with nintedanib at 5 μM for 24 h, and mRNA and protein levels of fibrosis‐related molecules (fibronectin and versican) were measured by real time qPCR and western blot, respectively. This evidence concerns the gene FN1 and leiomyoma.